Innova Captab Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Innova Captab Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹90Over the last 3 years, every ₹100 of reported profit came with ₹90 of operating cash.
Lower than 59% of Healthcare companies in India.
Self-Funding Ratio
0.6×Over the last 3 years its own operating cash paid for 62% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 78% of Healthcare companies in India.
Cash Locked Ratio
₹23For every ₹100 of sales, ₹23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹23 tied up three years earlier.
More money tied up than 50% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹11Sales grew 73% in 3 years; of every extra ₹100 of sales, ₹11 became extra profit.
Lower than 65% of Healthcare companies in India.
Asset Productivity Ratio
+73% / +161%In 3 years sales changed by +73% while total assets changed by +161%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.9×Debt due within a year is covered 0.9 times by its yearly operating cash.
Lower than 55% of Healthcare companies in India.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 66% of Healthcare companies in India.
Tangible Assets Ratio
99%Of every ₹100 the company owns, ₹99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in India.
Tangible Net Worth Ratio
98%Of every ₹100 of net worth, ₹98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 60% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Innova Captab Limited owes ₹0.41 for every ₹1 it owns. Net profit rose 10% in the year to Mar 2026, and grew 28% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
37.0Investors pay ₹37.0 for every ₹1 of Innova Captab Limited's yearly profit, higher than 52% of Healthcare companies in India.
P/B ratio
5.23The share price is 5.23 times Innova Captab Limited's book value per share, higher than 59% of Healthcare companies in India.
Market cap
₹5,702 CrThe total market value of all of Innova Captab Limited's shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,091 CrWhat Innova Captab Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹190.61Net worth divided by the number of shares. The share price of ₹996.50 is 5.2 times this, which is the P/B above.
Return on equity (ROE)
14.1%Innova Captab Limited earned 14.1% on its shareholders' money over the last year, higher than 57% of Healthcare companies in India.
Owes vs Owns
0.41×Innova Captab Limited owes ₹0.41 for every ₹1 it owns (low), higher than 61% of Healthcare companies in India.
Dividend yield
0.40%Innova Captab Limited pays 0.40% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in India.
Revenue growth
+30%Revenue rose 30% in the year to Mar 2026, and grew 20% a year on average over 3 years.
Profit growth
+10%Net profit rose 10% in the year to Mar 2026, and grew 28% a year on average over 3 years.
Profit margin
8.8%Innova Captab Limited keeps ₹9 of every ₹100 of revenue as net profit.
Cash quality
0.8×Cash from Innova Captab Limited's business was 0.8× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
11.2×Innova Captab Limited's operating profit covered its interest costs 11.2 times in the year to Mar 2026.
Cash vs debt
Net debtInnova Captab Limited had ₹299 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Innova Captab Limited's P/E ratio?
Investors pay ₹37.0 for every ₹1 of Innova Captab Limited's yearly profit, higher than 52% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Innova Captab Limited: ₹5,702 Cr ÷ ₹1,091 Cr (31 Mar 2026) = 5.2.
What is Innova Captab Limited's return on equity?
Innova Captab Limited earned 14.1% on its shareholders' money over the last year, higher than 57% of Healthcare companies in India.
How much does Innova Captab Limited owe compared with what it owns?
Innova Captab Limited owes ₹0.41 for every ₹1 it owns (low), higher than 61% of Healthcare companies in India.
Does Innova Captab Limited pay a dividend?
Yes. Innova Captab Limited pays 0.40% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in India.
Is Innova Captab Limited's revenue growing?
Revenue rose 30% in the year to Mar 2026, and grew 20% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.